Jens Jakob Thune

Københavns Universitet

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Emil Loldrup Fosbøl

DENMARK

View details

Jens Cosedis Nielsen

Professor of cardiology

Aarhus Universitet Health

DENMARK

View details

Casper N Bang

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jens Jakob Thune

Research Interests

Contact this professor

Articles (13)

Estimated Glomerular Filtration Rate and Implantable Cardioverter‐Defibrillator in Nonischemic Systolic Heart Failure: Extended Follow‐Up of DANISH

Pleural Effusion and Invasive Hemodynamic Measurements in Advanced Heart Failure

Atrial fibrillation onset before heart failure or vice versa: what is worst? A nationwide register study

Diabetes and Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure: An Extended Follow-Up Analysis of DANISH

NT-proBNP and ICD in Nonischemic Systolic Heart Failure: Extended Follow-Up of the DANISH Trial.

Effect of implantable cardioverter-defibrillators in patients with non-ischaemic systolic heart failure and concurrent coronary atherosclerosis.

Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy

Long-Term Follow-Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality).

Periodic Repolarization Dynamics Identifies ICD-responders in Non-ischemic Cardiomyopathy: A DANISH Substudy.

Prevalence and prognostic association of ventricular arrhythmia in non-ischaemic heart failure patients: results from the DANISH trial.

Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19.

Atrial fibrillation is a marker of increased mortality risk in nonischemic heart failure-Results from the DANISH trial.

Self-reported health status and the associated risk of mortality in heart failure: The DANISH trial.

Collaborators (3)

Emil Loldrup Fosbøl

Jens Cosedis Nielsen

Casper N Bang

Make your next move.